Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
Michael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 235-251.e9
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

A H3K27M-targeted vaccine in adults with diffuse midline glioma
Niklas Graßl, Isabel Poschke, Katharina A.M. Lindner, et al.
Nature Medicine (2023) Vol. 29, Iss. 10, pp. 2586-2592
Open Access | Times Cited: 46
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
Thomas Kerzel, Giovanna Giacca, Stefano Beretta, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1892-1910.e10
Open Access | Times Cited: 43
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning
Jonas Birkelund Nilsson, Saghar Kaabinejadian, Hooman Yari, et al.
Science Advances (2023) Vol. 9, Iss. 47
Open Access | Times Cited: 42
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 17
Glioblastoma induces the recruitment and differentiation of dendritic-like “hybrid” neutrophils from skull bone marrow
Meeki Lad, Angad Beniwal, Saket Jain, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1549-1569.e16
Closed Access | Times Cited: 16
Challenges and advances in the management of inflammation in atherosclerosis
Yiming Xing, Xianhe Lin
Journal of Advanced Research (2024)
Open Access | Times Cited: 12
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma
Wei Zhu, Zhiming Zhang, Jinzhang Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient
Tamara Boschert, Kristina Kromer, Taga Lerner, et al.
Science Advances (2024) Vol. 10, Iss. 5
Open Access | Times Cited: 8
Vaccine-based immunotherapy and related preclinical models for glioma
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 7
Exosome‐transmitted podoplanin promotes tumor‐associated macrophage‐mediated immune tolerance in glioblastoma
Mengwan Wu, Ying Shi, Yuyang Liu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 6
Clinical and Translational Advances in Glioma Immunotherapy
Lukas Bunse, Theresa Bunse, Christopher M. Kramer, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1799-1817
Open Access | Times Cited: 27
TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
Xuezhen Chen, Yue Zhao, Yimin Huang, et al.
Glia (2023) Vol. 71, Iss. 11, pp. 2679-2695
Open Access | Times Cited: 14
Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment
Yan Lv, Mengyuan Li, Ling Weng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer
Xi Li, Alfonso Poire, Kang Jin Jeong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion
Jessica Waibl Polania, Alexandra Hoyt-Miggelbrink, William H. Tomaszewski, et al.
Immunity (2024)
Open Access | Times Cited: 5
TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas
Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 5, pp. 811-825
Open Access | Times Cited: 12
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
Bryan Gardam, Tessa Gargett, Michael P. Brown, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment
Haiyan Xu, Shengbai Xue, Yang Sun, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010029-e010029
Open Access
Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma
Jeffrey M Grimes, Sadashib Ghosh, Shaista Manzoor, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
Blocking ITGA5 potentiates the efficacy of anti‐PD‐1 therapy on glioblastoma by remodeling tumor‐associated macrophages
Rongrong Zhao, Ziwen Pan, Jiawei Qiu, et al.
Cancer Communications (2025)
Open Access
scNET: learning context-specific gene and cell embeddings by integrating single-cell gene expression data with protein–protein interactions
Ron Sheinin, Roded Sharan, Asaf Madi
Nature Methods (2025)
Open Access
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Ruth Plummer, Mikael H. Sodergren, Rose Hodgson, et al.
Cell Reports Medicine (2025), pp. 102041-102041
Open Access
ZEB2 is a master switch controlling the tumor-associated macrophage program
Fadi Sheban, Truong San Phan, Kaikun Xie, et al.
Cancer Cell (2025)
Closed Access
Page 1 - Next Page

Scroll to top